2,2,5,7,8-pentamethyl-1-hydroxychroman has been researched along with Injury, Ischemia-Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Chou, DS; Hsiao, G; Lee, JJ; Lin, JH; Lin, KH; Shen, MY; Sheu, JR | 1 |
| Henning, RH; Krenning, G; Nakladal, D; Swart, DH; Tkáčiková, Ľ; Tkáčiková, S; van der Graaf, AC; Vogelaar, PC | 1 |
2 other study(ies) available for 2,2,5,7,8-pentamethyl-1-hydroxychroman and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Neuroprotective effects of PMC, a potent alpha-tocopherol derivative, in brain ischemia-reperfusion: reduced neutrophil activation and anti-oxidant actions.
Topics: alpha-Tocopherol; Animals; Antioxidants; Caspase 3; Chromans; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Ischemia, Brain; Male; Molecular Structure; Neuroprotective Agents; Neutrophil Activation; Neutrophils; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Reperfusion Injury; Tyrosine | 2007 |
Towards prevention of ischemia-reperfusion kidney injury: Pre-clinical evaluation of 6-chromanol derivatives and the lead compound SUL-138
Topics: Acute Kidney Injury; Animals; Chromans; HEK293 Cells; Humans; Ischemia; Kidney; Lead; Mice; Rats; Reperfusion; Reperfusion Injury; Translational Science, Biomedical | 2022 |